189 related articles for article (PubMed ID: 30753456)
1. Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and Infliximab.
Gregory MH; Ciorba MA; Deepak P; Christophi GP
Inflamm Bowel Dis; 2019 Jun; 25(7):e87-e88. PubMed ID: 30753456
[No Abstract] [Full Text] [Related]
2. Efficacy of tofacitinib treatment in ulcerative colitis.
Panés J; Gisbert JP
Gastroenterol Hepatol; 2019; 42(6):403-412. PubMed ID: 31101342
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib for the Treatment of Pyoderma Gangrenosum.
Kochar B; Herfarth N; Mamie C; Navarini AA; Scharl M; Herfarth HH
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):991-993. PubMed ID: 30404036
[TBL] [Abstract][Full Text] [Related]
4. Tofacitinib for the treatment of refractory pyoderma gangrenosum.
Orfaly VE; Kovalenko I; Tolkachjov SN; Ortega-Loayza AG; Nunley JR
Clin Exp Dermatol; 2021 Aug; 46(6):1082-1085. PubMed ID: 33864685
[TBL] [Abstract][Full Text] [Related]
5. The Era of Anti-Tumor Necrosis Factor Is Over. What Do We Know, What Don't We Know, and What Do We Yearn to Know?
Dwadasi S; Israel A; Rubin DT
Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):405-419. PubMed ID: 31078244
[No Abstract] [Full Text] [Related]
6. Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
Sedano R; Jairath V
Inflamm Bowel Dis; 2021 Apr; 27(5):e65. PubMed ID: 33484124
[No Abstract] [Full Text] [Related]
7. Tofacitinib for familial Mediterranean fever: a new alternative therapy?
Garcia-Robledo JE; Aragón CC; Nieto-Aristizabal I; Posso-Osorio I; Cañas CA; Tobón GJ
Rheumatology (Oxford); 2019 Mar; 58(3):553-554. PubMed ID: 30535114
[No Abstract] [Full Text] [Related]
8. Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy.
Bobbitt SA; Klaus EM; Stringer E; Chowdhury D; Finlayson L
Dermatol Online J; 2016 Apr; 22(4):. PubMed ID: 27617462
[TBL] [Abstract][Full Text] [Related]
9. Topical tofacitinib in treatment of alopecia areata.
Ferreira SB; Ferreira RB; Scheinberg MA
Einstein (Sao Paulo); 2020; 18():eAI5452. PubMed ID: 32785452
[No Abstract] [Full Text] [Related]
10. Tofacitinib in pyoderma gangrenosum - A case series.
Sathyanarayana VA; Roy D; Nagaraju B; Rao VKR
Int J Rheum Dis; 2024 Jan; 27(1):e14810. PubMed ID: 37395471
[TBL] [Abstract][Full Text] [Related]
11. [Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis].
Krag AA; Gjersøe P
Ugeskr Laeger; 2005 May; 167(18):1968-9. PubMed ID: 15929274
[No Abstract] [Full Text] [Related]
12. [Tofacitinib].
Döker S; Dewenter M; El-Armouche A
Dtsch Med Wochenschr; 2014 May; 139(19):1003-8. PubMed ID: 24782154
[TBL] [Abstract][Full Text] [Related]
13. A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.
Sato S; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Furuya M; Gunji N; Fujiwara T; Asano T; Onizawa M; Kobayashi H; Watanabe H; Ohira H; Migita K
Rheumatology (Oxford); 2020 Jul; 59(7):1773-1775. PubMed ID: 31776552
[No Abstract] [Full Text] [Related]
14. Successful treatment of arthritis and rash with tofacitinib in systemic lupus erythematosus: the experience from a single centre.
You H; Zhang G; Wang Q; Zhang S; Zhao J; Tian X; Li H; Li M; Zeng X
Ann Rheum Dis; 2019 Oct; 78(10):1441-1443. PubMed ID: 31005902
[No Abstract] [Full Text] [Related]
15. Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab.
Fortuny Bauzá M; Cañete Pizarro F; Calm Salvans A; Calafat Sard M; Domènech Morral E
Gastroenterol Hepatol; 2022 Apr; 45 Suppl 1():11-12. PubMed ID: 34118322
[No Abstract] [Full Text] [Related]
16. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
Mrowietz U; Gerdes S; Gläser R; Schröder O
Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
[No Abstract] [Full Text] [Related]
17. Tofacitinib for the treatment of recalcitrant palmoplantar pustulosis: A case report.
Haynes D; Topham C; Hagstrom E; Greiling T
Australas J Dermatol; 2020 Feb; 61(1):e108-e110. PubMed ID: 31318041
[No Abstract] [Full Text] [Related]
18. Alopecia universalis. Partial response to tofacitinib.
Ruiz-Villaverde R; Cuenca-Barrales C; Linares-Gonzalez L; Ródenas-Herranz T
Med Clin (Barc); 2019 Aug; 153(3):e15. PubMed ID: 30718001
[No Abstract] [Full Text] [Related]
19. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
20. XELJANZ (Tofacitinib) for Chronic Plaque Psoriasis.
Gupta AK; Daigle D; Abramovits W; Vincent KD
Skinmed; 2015; 13(3):227-9. PubMed ID: 26380510
[No Abstract] [Full Text] [Related]
[Next] [New Search]
